Pushing von Eschenbach
This article was originally published in The Gray Sheet
Executive Summary
Senate HELP Committee Chairman Michael Enzi (R-Wyo.) calls Nov. 16 for a lame-duck session floor vote to nominate FDA Acting Commissioner Andrew von Eschenbach to the permanent post. Incoming committee chair Edward Kennedy (D-Mass.) also supports the nomination. The same day, Senate Finance Committee Chairman Chuck Grassley (R-Iowa) placed a hold on von Eschenbach's nomination for his failure to comply with committee subpoenas. Fellow Republican Sens. David Vitter (La.) and Jim DeMint (S.C.) already have holds in place (1"The Gray Sheet" Sept. 25, 2006, p. 8)...